These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11525101)

  • 41. Impact of fecal occult blood on obscure gastrointestinal bleeding: observational study.
    Kobayashi Y; Watabe H; Yamada A; Suzuki H; Hirata Y; Yamaji Y; Yoshida H; Koike K
    World J Gastroenterol; 2015 Jan; 21(1):326-32. PubMed ID: 25574108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
    Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test.
    Mousavinezhad M; Majdzadeh R; Akbari Sari A; Delavari A; Mohtasham F
    Med J Islam Repub Iran; 2016; 30():366. PubMed ID: 27493910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An audit of the utility of in-patient fecal occult blood testing.
    Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
    Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?
    Lang CA; Ransohoff DF
    JAMA; 1994 Apr; 271(13):1011-3. PubMed ID: 8139058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
    Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of fecal occult blood test as a screening test before capsule endoscopy.
    Efthymiou M; Allen PB; Jayasekera C; Taylor PV; Taylor AC
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):690-4. PubMed ID: 21677588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of faecal occult blood tests requested outside the UK National Bowel Cancer Screening Programme.
    McDonald R; Tomlins A; Smith S; Harmston C
    J Clin Pathol; 2013 Apr; 66(4):330-4. PubMed ID: 23288919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia?
    Robinson MH; Thomas WM; Pye G; Hardcastle JD; Mangham CM
    Eur J Surg Oncol; 1993 Dec; 19(6):539-42. PubMed ID: 8270040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience.
    Zappa M; Castiglione G; Paci E; Grazzini G; Rubeca T; Turco P; Crocetti E; Ciatto S
    Int J Cancer; 2001 Apr; 92(1):151-4. PubMed ID: 11279619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood.
    Castiglione G; Grazzini G; Miccinesi G; Rubeca T; Sani C; Turco P; Zappa M
    J Med Screen; 2002; 9(3):99-103. PubMed ID: 12370319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fecal occult blood test--the importance of proper evaluation.
    Niv Y
    J Clin Gastroenterol; 1990 Aug; 12(4):393-5. PubMed ID: 2398247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunochemical detection of fecal occult blood.
    Frommer D; Kapparis A; Brown M
    Aust N Z J Med; 1985 Aug; 15(4):453-4. PubMed ID: 3910011
    [No Abstract]   [Full Text] [Related]  

  • 57. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.
    Sinatra MA; St John DJ; Young GP
    Clin Chem; 1999 Jan; 45(1):123-6. PubMed ID: 9895348
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.